Funded by the Bill and Melinda Gates Foundation, the A∙WOL Consortium consists of both academic and industrial partners whose aim is to develop a new chemotherapy treatment against Wolbachia - a bacterial endosymbiont of filarial nematodes responsible for onchocerciasis (river blindness) and lymphatic filariasis (elephantiasis). This portal features an overview of the programme and its partners, latest news releases, upcoming meetings and a list of related articles. It also includes descriptive pages about onchocerciasis and lymphatic filariasis.
